Study of Influenza Virus Infection in Children Hospitalized in Spain in Two Consecutive Influenza Seasons
NCT ID: NCT04008823
Last Updated: 2019-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
907 participants
OBSERVATIONAL
2017-10-05
2017-12-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years
NCT00372255
Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children
NCT00408395
Evaluation of Moderate to Severe Influenza Outcomes in Children
NCT02979626
Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China
NCT00760500
Swine Flu (Novel Influenza A H1N1) Vaccine Study
NCT00980850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Retrospective and observational epidemiological study, by review of clinical histories,
Retrospective and observational epidemiological study, by review of clinical histories,
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With a clinical diagnosis of influenza virus infection.
* With infection by influenza virus confirmed microbiologically.
* Hospitalized more than 24 hours
Exclusion Criteria
* That the clinical diagnosis is not influenza virus infection.
* Influenza virus not confirmed by microbiological diagnosis.
* Not hospitalized or hospitalized for less than 24 hours.
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biogipuzkoa Health Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Iis Biodonostia
San Sebastián, Guipuzcoa, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HOSPIGRIP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.